ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2012
Epidemiology and management of hypertension in the Hispanic population: a review of the available literature.
Review in American journal of cardiovascular drugs : drugs, devices, and other interventions, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 38 citations in OpenAlex.
- A Systems-Level Approach to Improving Medication Adherence in Hypertensive Latinos: a Randomized Control Trial.Journal of general internal medicine · 2020Trial
- Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.American journal of hypertension · 2017Trial
- Racial and ethnic differences in cardiometabolic predictors of white matter hyperintensities burden among males: The HABS-HD study.Journal of Alzheimer's disease : JAD · 2025Article
- Article
- Review
- Hypertension Prevalence and Related Risk Factors Among Mexican American Adults Are Increasing: National Health and Nutrition Examination Survey 1999 to 2018.Journal of the American Heart Association · 2024Article
- A Cyclical Model of Barriers to Healthcare for the Hispanic/Latinx Population.Journal of racial and ethnic health disparities · 2024Review
- Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension.Frontiers in psychiatry · 2024Article
- Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design.American heart journal · 2023Article
- Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population.World journal of surgery · 2021Article
- A Web-Based Positive Psychological Intervention to Improve Blood Pressure Control in Spanish-Speaking Hispanic/Latino Adults With Uncontrolled Hypertension: Protocol and Design for the ¡Alégrate! Randomized Controlled Trial.JMIR research protocols · 2020Article
- Predictors for Blood Pressure Reduction in American Latinos: Secondary Analysis of the Adelgaza Program Data.Hispanic health care international : the official journal of the National Association of Hispanic Nurses · 2020Article
- Neighbourhood-level deprivation indices and postpartum women's health: results from the Community Child Health Network (CCHN) multi-site study.Health and quality of life outcomes · 2020Article
- "Contemporary clinical trials communications · 2019Article
- RIDDLE: Race and ethnicity Imputation from Disease history with Deep LEarning.PLoS computational biology · 2018Article
- The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.PloS one · 2018Article
- Vitamin D and its effects on cardiovascular diseases: a comprehensive review.The Korean journal of internal medicine · 2016Review
- Feasibility of Spanish-language acquisition for acute medical care providers: novel curriculum for emergency medicine residencies.Advances in medical education and practice · 2016Article
- Identification of Barriers to Stroke Awareness and Risk Factor Management Unique to Hispanics.International journal of environmental research and public health · 2015Article
- Health status, perceptions and needs of Hispanics in rural Shelbyville, Kentucky.Journal of immigrant and minority health · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hispanics are the fastest growing ethnic minority in the USA. Among Hispanics, lack of hypertension awareness and lack of effective blood pressure (BP) control are problematic, as are higher incidence rates of hypertension-related co-morbidities compared with non-Hispanic populations. Moreover, there are currently no hypertension treatment guidelines that address the unique characteristics of this ethnic group. This article discusses ethnic differences in hypertension and cardiovascular risk factors and reviews the literature on the efficacy of antihypertensive agents in Hispanic patients, with a focus on the role of renin-angiotensin-aldosterone system (RAAS) inhibition in the management of hypertension in these patients. Hypertension in Hispanic patients can be challenging to manage, in part because this population has a higher prevalence of obesity, diabetes, and metabolic syndrome compared with non-Hispanic whites. The presence of these co-morbidities suggests that RAAS-inhibitor-based therapies may be particularly beneficial in this population. However, few studies have evaluated the efficacy of antihypertensive treatments in Hispanic patients. Two outcomes studies in hypertensive patients have shown the benefits of treating Hispanic patients with antihypertensive therapy and included RAAS inhibitors as part of the treatment regimen. In addition, BP-lowering trials have shown the antihypertensive efficacy of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors, although data on the latter are more limited. Additional studies are needed to more thoroughly evaluate the effects of RAAS inhibitors (and other drug classes) on outcomes and BP lowering in the Hispanic hypertensive population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.